bims-mihora Biomed News
on Mitohormesis, repair and aging
Issue of 2026–03–29
25 papers selected by
Lisa Patel, Istesso



  1. Front Cell Infect Microbiol. 2026 ;16 1795935
      Mitochondria are central hubs integrating cellular bioenergetics, redox balance, innate immune signaling, and metabolic homeostasis. During bacterial infections, these organelles are recurrent targets of pathogen-derived toxins, secreted effectors, and host inflammatory mediators, leading to a state broadly defined as mitochondrial stress. This stress encompasses alterations in oxidative phosphorylation, mitochondrial dynamics, calcium handling, reactive oxygen species (ROS) production, and activation or disruption of mitochondrial quality control pathways such as mitophagy. In this perspective, we propose mitochondrial stress as a conceptual framework linking bacterial infection and post-infectious metabolic disease. Using enteric bacterial pathogens such as Salmonella enterica serovars Typhimurium and Typhi, together with Vibrio parahaemolyticus, as conceptual models, we synthesize current evidence showing how distinct bacterial strategies converge on mitochondrial dysfunction and immunometabolic reprogramming of host cells. We argue that, while mitochondrial stress responses may initially support antimicrobial defense, their incomplete resolution may contribute to long-lasting metabolic and inflammatory alterations in epithelial, immune, and metabolic tissues. Persistent mitochondrial dysfunction may contribute to insulin resistance, chronic inflammation, and increased susceptibility to metabolic disease after infection. By framing mitochondrial stress as a central integrator of infection and metabolism, this perspective highlights key knowledge gaps and identifies mitochondria-centered pathways as potential targets to prevent or mitigate post-infectious metabolic sequelae.
    Keywords:  Salmonella enterica; Vibrio parahaemolyticus; bacterial infection; immunometabolism; mitochondrial stress; post-infectious metabolic disease
    DOI:  https://doi.org/10.3389/fcimb.2026.1795935
  2. Biomedicines. 2026 Mar 12. pii: 636. [Epub ahead of print]14(3):
      Background: Population aging is significantly altering the clinical conditions of peripheral nerve injury (PNI); however, the age-specific mechanisms that affect nerve regeneration remain unclear. Although the peripheral nervous system has the potential for regeneration, functional recovery after peripheral nerve injury is unsatisfactory in elderly people. The current research mainly focuses on young organisms, leaving a crucial gap in our understanding of how aging fundamentally alters the regenerative microenvironment and affects final therapeutic outcome. This review aims to integrate the latest evidence on aging-related changes in peripheral nerve repair and clarify the underlying mechanism of failed nerve regeneration in elderly people. Summary: An increasing amount of data indicates that aging not only delays the regenerative process but also significantly affects the nervous system's microenvironment. In an aging environment, chronic low-level inflammation (known as "inflammaging") caused by mitochondrial dysfunction, Schwann cell senescence, and abnormal macrophages impedes axon regeneration. Moreover, aging cells secrete pro-inflammatory mediators such as interleukin-6 and tumor necrosis factor-α, strengthening the paracrine aging process and establishing a positive feedback inflammatory cycle. We therefore integrated a metabolic-immune-aging framework to explain age-related regenerative resistance and emphasize the transformation barriers limiting clinical applications. Conclusions: Understanding the systems-level interactions within the aging nerve microenvironment is essential for developing age-tailored therapeutic strategies. Targeting metabolic dysfunction, immune dysregulation, and cellular senescence may offer new avenues for improving functional recovery in elderly patients with PNI.
    Keywords:  Schwann cells; aging; cellular senescence; inflammaging; macrophage polarization; mitochondrial dysfunction; nerve repair; neuroinflammation; oxidative stress; peripheral nerve regeneration
    DOI:  https://doi.org/10.3390/biomedicines14030636
  3. Cancer Discov. 2026 Mar 27. OF1
      Two studies show that cancer cells co-opt the integrated stress response, via the transcription factor ATF4, to drive both metastasis and immune evasion. Targeting this pathway or its downstream effectors, such as glutamine metabolism and the secreted protein LCN2, may offer a way to limit tumor spread and restore antitumor immunity.
    DOI:  https://doi.org/10.1158/2159-8290.CD-NW2026-0029
  4. Biomolecules. 2026 03 20. pii: 467. [Epub ahead of print]16(3):
      Cardiovascular disease remains the leading global cause of mortality, largely due to the limited regenerative capacity of adult human myocardium. Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offer a scalable platform for cardiac repair and disease modeling; however, their persistent metabolic immaturity-characterized by reliance on glycolysis, reduced oxidative phosphorylation (OXPHOS), and structurally underdeveloped mitochondria-limits functional integration and long-term therapeutic efficacy. Recent advances indicate that targeted metabolic reprogramming can enhance mitochondrial biogenesis, increase ATP production, and improve stress resilience in iPSC-CMs. This review examines the complementary integration of CRISPR-based metabolic engineering and extracellular vesicle (EV)-mediated metabolic modulation as a systems-level strategy for cardiac maturation. We discuss CRISPR activation, interference, and epigenome-editing approaches targeting regulators such as PGC-1α, TFAM, and PPARs to promote stable enhancement of mitochondrial networks and respiratory capacity. In parallel, engineered EVs delivering miRNAs, metabolic enzymes, and redox modulators provide non-genomic mechanisms to optimize bioenergetic function and mitigate oxidative stress. By synthesizing mechanistic insights, quantitative bioenergetic metrics, and translational considerations, we propose CRISPR-EV synergy as a precision framework for durable metabolic maturation of iPSC-CMs, with implications for regenerative therapy, pharmacologic screening, and myocardial repair.
    Keywords:  CRISPR metabolic engineering; EV bioengineering; cardiac regeneration; cardiomyocyte maturation; extracellular vesicles; iPSC-derived cardiomyocytes; metabolic biomarkers; metabolic reprogramming; mitochondrial biogenesis; oxidative phosphorylation
    DOI:  https://doi.org/10.3390/biom16030467
  5. Front Immunol. 2026 ;17 1750974
      Chronic inflammatory and autoimmune conditions frequently manifest as multi-organ dysfunction without a single explanatory lens that integrates metabolic stress, innate immune activation, transcriptional control, and autonomic regulation. Here, we propose the Bio-Intelligence Circuit (BIC) as a hypothesis-generating systems framework connecting mitochondrial dysfunction, LPS-TLR4-NF-κB innate immune signaling, nuclear receptor dysregulation, and vagal reflex imbalance as interacting regulatory failure patterns that may sustain chronic inflammatory states. The central hypothesis is that loss of coordinated energetic, immune-sensing, and neuro-autonomic regulation sustains a self-reinforcing dysregulation loop that amplifies inflammatory signaling, impairs regulatory restraint, and limits recovery potential. Within this framework, we introduce Informational Bio-Recalibration (IBR) as a hypothesis-generating transition sequence in which improvement of mitochondrial bioenergetics and redox buffering, attenuation of excessive TLR4 signaling, restoration of nuclear receptor transcriptional coordination, and rebalancing of autonomic tone may together shift the system toward resolution-permissive physiology. This article does not report interventional outcomes; rather, it provides a structured conceptual model and testable predictions to guide future experimental validation across inflammatory and immune-mediated phenotypes.
    Keywords:  bio-intelligence circuit; chronic inflammation; hypothesis-generating framework; immune dysregulation; informational bio-recalibration; mitochondrial bioenergetics; nuclear receptor coordination; systems biology
    DOI:  https://doi.org/10.3389/fimmu.2026.1750974
  6. Front Physiol. 2026 ;17 1759575
      Cerebral ischemia-reperfusion injury remains a leading cause of mortality and disability despite advances in reperfusion therapy. Traditional research has focused on individual cell death pathways, yet pharmacological blockade of single pathways provides only partial neuroprotection, suggesting that dying cells engage multiple death routes simultaneously. This review examines whether PANoptosis, an inflammatory cell death modality characterized by concurrent activation of apoptotic, necroptotic, and pyroptotic pathways, occurs in cerebral ischemia-reperfusion injury. The analysis demonstrates that mitochondrial dysfunction serves as the central convergence point orchestrating multi-pathway death activation across distinct temporal phases. Ischemia creates metabolic crisis that primes mitochondria without triggering irreversible commitment. Reperfusion causes explosive mitochondrial collapse through oxidative stress, releasing danger signals that simultaneously engage multiple death pathways. Impaired mitochondrial quality control then sustains inflammatory amplification over extended periods. Multiple lines of evidence support this framework, including concurrent rather than sequential appearance of pathway markers, mixed morphological features within individual cells, pathway redundancy demonstrated by incomplete single-target protection, and mechanistic convergence at the mitochondrial level. Cellular responses vary among neurons, astrocytes, microglia, and endothelial cells but share the common feature of coordinated multi-pathway activation. This integrated understanding explains why single-pathway therapeutic approaches have failed clinically and suggests that effective neuroprotection requires targeting upstream mitochondrial dysfunction or addressing pathway redundancy through multi-target interventions.
    Keywords:  PANoptosis; cell death pathways; cerebral ischemia-reperfusion injury; mitochondrial dysfunction; neuroinflammation; neuroprotection
    DOI:  https://doi.org/10.3389/fphys.2026.1759575
  7. Am J Physiol Cell Physiol. 2026 Mar 26.
      Skeletal muscle plays a central role in systemic metabolism, physical function, and overall health. Aging and disease diminish the ability of myogenic and non-myogenic skeletal muscle cells to coordinate adaptation and repair, but the mechanisms underlying this decline are not fully understood. Growing evidence implicates cellular senescence, a stress response marked by irreversible cell-cycle arrest and pro-inflammatory signaling, as a key contributor to muscle pathology. In this review, we synthesize current insights into the molecular mechanisms that govern cellular senescence in skeletal muscle, its effects on myogenic and non-myogenic cell populations, and recent technologies that have clarified key aspects of senescence biology. We further explore emerging therapeutic strategies aimed at targeting senescent cells and discuss key knowledge gaps that must be addressed to advance our understanding of senescent myogenic and non-myogenic cells in skeletal muscle.
    Keywords:  DNA damage; cell cycle; inflammation; muscle wasting; satellite cells
    DOI:  https://doi.org/10.1152/ajpcell.00876.2025
  8. Trends Mol Med. 2026 Mar 20. pii: S1471-4914(26)00011-0. [Epub ahead of print]
      Aging, once viewed as an irreversible process, is now considered a modifiable process. Recent advances in cellular reprogramming reveal that transient expression of reprogramming factors can reverse molecular hallmarks of aging while preserving somatic cell identity. This 'partial reprogramming' rejuvenates tissues, restores regenerative capacity, and, in some models, extends lifespan without the tumorigenic risks of full dedifferentiation. In this review, we summarize genetic and chemical strategies for partial reprogramming, discuss their tissue-specific effects in vivo, and evaluate their implications for tissue regeneration and age-related disease. We further examine key challenges for clinical translation, including safety, delivery strategies, and temporal control of reprogramming.
    Keywords:  aging; chemical reprogramming; partial genetic reprogramming; rejuvenation
    DOI:  https://doi.org/10.1016/j.molmed.2026.01.007
  9. Toxicology. 2026 Mar 20. pii: S0300-483X(26)00059-4. [Epub ahead of print]523 154452
      Polystyrene microplastics (PS-MPs) have emerged as pervasive environmental contaminants with growing concerns regarding their potential adverse effects on human health; however, their impact on skeletal muscle homeostasis remains poorly understood. In this study, we investigated the effects of PS-MPs on muscle atrophy and the underlying molecular mechanism using differentiated C2C12 myotubes. Cells were exposed to 1 μm PS-MPs for 24 h, which resulted in a dose-dependent increase in intracellular reactive oxygen species levels at concentrations of 100-500 μg/mL. PS-MPs significantly upregulated the gene and protein expression of muscle atrophy-related markers, including myostatin, atrogin-1, and MuRF1, and increased polyubiquitinated proteins, while markedly suppressed muscle protein synthesis-related markers such as MyoD1, MyoG, and MHC, as well as overall protein synthesis, as determined by puromycin labeling. Mechanistically, PS-MPs remarkably downregulated IGF-1-PI3K-Akt-mTOR signaling pathway, while concomitantly activating AMPK and FoxO3α signaling. Intracellular accumulation of PS-MPs was accompanied by mitochondrial swelling and cristae disruption. Consistently, PS-MPs induced mitochondrial dysfunction, as evidenced by mitochondrial depolarization, decreased ATP production, and reduced expression of PGC-1α, NRF1, TFAM, and OXPHOS proteins. Oxidative stress responses were further characterized by the upregulation of Keap1 and the suppression of NRF2 and HO-1 expression. PS-MPs alone elicited a muscle atrophy phenotype comparable to that caused by dexamethasone, and co-exposure synergistically enhanced the expression of atrogin-1, MuRF1, and myostatin genes. In conclusion, these findings demonstrate that PS-MPs disrupt muscle homeostasis by inhibiting IGF-1-PI3K-Akt signaling, promoting oxidative stress, and impairing mitochondrial integrity, confirming PS-MPs as a previously unrecognized environmental hazard that may contribute to muscle atrophy.
    Keywords:  C2C12 myotube; Mitochondria; Muscle atrophy; Oxidative stress; Polystyrene microplastics
    DOI:  https://doi.org/10.1016/j.tox.2026.154452
  10. Biology (Basel). 2026 Mar 13. pii: 466. [Epub ahead of print]15(6):
      Spermatogenesis is a metabolically intensive process that is highly sensitive to perturbations in proteostasis. The integrated stress response (ISR) and its central effector, ATF4, orchestrate adaptive responses to maintain cellular homeostasis under stress; however, the functional significance of ATF4 in mammalian spermatogenesis has not been established. To investigate this, we engineered a conditional knockout mouse model with germ cell-specific deletion of the Atf4 gene. Results showed that Atf4 deletion did not impair spermatogenesis or male fertility, with knockout mice exhibiting normal testicular histology and standard sperm parameters. Proteomic analysis, however, revealed that ATF4 contributes to testicular protein expression homeostasis, as its deficiency caused marked dysregulation of the testicular proteome, especially impacting SQSTM1/p62 downregulate through endoplasmic reticulum (ER) stress pathway. We conclude that ATF4's role in regulating proteostatic balance is functionally decoupled from its necessity for the core progression of spermatogenesis. These findings define ATF4 as a potential resilience agent safeguarding testicular function under ER stress, rather than a direct regulator of male germ cell development.
    Keywords:  Atf4; ER stress; integrated stress response; male fertility; spermatogenesis
    DOI:  https://doi.org/10.3390/biology15060466
  11. J Cell Biol. 2026 Apr 06. pii: e202603036. [Epub ahead of print]225(4):
      In this issue, Yan et al. show that mitochondrial targeting signals (presequences) vary widely in import strength. Using the quantitative MitoLuc and PotLuc assays, they dissect multiple parameters of protein import and reveal how presequence features influence mitochondrial targeting efficiency and stress sensitivity.
    DOI:  https://doi.org/10.1083/jcb.202603036
  12. Biomed Khim. 2026 Feb;72(1): 5-20
      The VPS35 is an essential protein that plays multifunctional roles in various biological processes. It is a core component of the retromer complex, involved in protein recycling from endosomes to the trans-Golgi network (TGN) and the plasma membrane. Besides its role as the retromer complex component, VPS35 interacts with many proteins and regulates mitochondrial homeostasis, mitochondrial dynamics (fusion and fission), and other important processes in various cell compartments. In the context of Parkinson's disease (PD) convincing evidence exists that VPS35 mutations, particularly [D620N], have a significant impact on normal retromer functioning, mitochondrial dysfunction, and impairment of neuronal health and survival. In this review we briefly consider structure and functions of the retromer complex, the role of VPS35 in mitochondria, and finally analyze physical and functional interactions of this protein with PD-important proteins associated with mitochondria.
    Keywords:  VPS35; mitochondria; mitochondrial dysfunction; neurodegeneration; retromer complex
    DOI:  https://doi.org/10.18097/PBMCR1648
  13. Biomolecules. 2026 03 16. pii: 445. [Epub ahead of print]16(3):
      Mitochondrial reactive oxygen species (mtROS) play a dual role in retinal physiology, acting as essential redox signalling mediators under homeostatic conditions but driving oxidative damage and neurodegeneration once regulatory thresholds are exceeded. Owing to the exceptionally high energetic demands of retinal neurons and supporting cells, even subtle perturbations in mitochondrial redox balance can precipitate progressive retinal dysfunction. Increasing evidence indicates that retinal neurodegenerative diseases, including glaucoma, diabetic retinopathy (DR), age-related macular degeneration (AMD), and inherited optic neuropathies, are characterised not by uniform oxidative stress, but by disease- and stage-specific mtROS signatures shaped by mitochondrial quality control capacity. This review synthesises current insights into the sources, regulation, and signalling functions of mtROS in the retina, with particular emphasis on threshold-dependent redox transitions, reverse electron transport, and the progressive failure of mitochondrial quality control mechanisms, including mitophagy, mitochondrial dynamics, and redox-responsive transcriptional networks. The limitations of non-selective antioxidant strategies are critically examined, highlighting why indiscriminate ROS suppression has yielded limited clinical benefit. In contrast, emerging therapeutic approaches aimed at recalibrating mitochondrial redox homeostasis, rather than abolishing physiological signalling, are discussed in the context of disease stage, metabolic state, and mitochondrial competence. By integrating redox biology with mitochondrial quality control and precision medicine concepts, this review proposes a unifying framework in which retinal neurodegeneration is governed by regulated mtROS signalling and the progressive exhaustion of mitochondrial resilience. This model defines critical therapeutic windows for mitochondria-targeted intervention and provides a framework for biomarker-guided patient stratification.
    Keywords:  mitochondria-targeted intervention; mitochondrial quality control; mitochondrial reactive oxygen species (mtROS); mitophagy; precision medicine; redox signalling; retinal ganglion cells; retinal neurodegeneration; reverse electron transport
    DOI:  https://doi.org/10.3390/biom16030445
  14. Psychopharmacology (Berl). 2026 Mar 23.
      
    Keywords:  Accelerated forgetting; ISRIB; Inflammation; Recognition memory
    DOI:  https://doi.org/10.1007/s00213-026-07046-3
  15. Stem Cell Res Ther. 2026 Mar 22.
       BACKGROUND: Circadian rhythms are endogenous, transcription-translation feedback loops that align cellular activities with the 24-h light-dark cycle. Stem-cell populations across tissues exhibit circadian oscillations that influence their self-renewal, proliferation, and differentiation. Key developmental pathways (Wnt/β-catenin, Notch, and Hedgehog) are increasingly recognized as both regulators and targets of circadian machinery.
    OBJECTIVES: This review synthesizes current knowledge on the bidirectional crosstalk between circadian clock components and major stem-cell regulatory pathways, and evaluates how this interplay shapes tissue homeostasis, regenerative capacity, and therapeutic potential.
    METHODS: Literature examining molecular interfaces between circadian clock genes and Wnt, Notch, and Hedgehog signaling was surveyed, with emphasis on transcriptional regulation, chromatin dynamics, post-translational control, and functional outcomes for stem-cell behavior and regeneration.
    RESULTS: Evidence indicates that core clock components modulate stem-cell pathways through direct transcriptional control, shared enhancer architecture, altered chromatin accessibility, and rhythmic protein modification. In turn, Wnt, Notch, and Hedgehog signals feed back onto clock genes, influencing circadian amplitude and phase within stem-cell niches. Perturbation of this reciprocal regulation disrupts tissue maintenance, diminishes regenerative responses, alters metabolic equilibrium, and may promote tumorigenesis.
    CONCLUSIONS: Circadian oscillators act as temporal gatekeepers of stem-cell function. Mapping the molecular interfaces between clock genes and developmental signaling pathways reveals new opportunities to refine regenerative therapies. Chronotherapeutic strategies, i.e. timing interventions to intrinsic circadian phases may enhance the efficacy, precision, and safety of stem-cell-based treatments.
    Keywords:  Ageing; BMAL1; Chronotherapy; Circadian clocks; Regeneration; Stem cells
    DOI:  https://doi.org/10.1186/s13287-026-04979-6
  16. Front Cell Dev Biol. 2026 ;14 1756033
      Chronic obstructive pulmonary disease (COPD) is a common chronic condition characterized by chronic bronchitis and/or emphysema with airflow obstruction, which can progress to cor pulmonale and respiratory failure. Associated with abnormal inflammatory responses to harmful gases and particulate matter, it carries high rates of disability and mortality, with a global prevalence among individuals aged 40 and older reaching 9%-10%. It is often regarded as a clinical and molecular model of accelerated lung aging. Age-related drift in immune function and metabolism plays a central part in this process, but how these changes are linked across different biological levels is still not fully clarified. Current work highlights mitochondrial injury and excessive reactive oxygen species as a central node that disrupts energy-sensing pathways, interferes with autophagy and epigenetic control, and weakens mitochondrial biogenesis, together fostering long-term glycolipid imbalance. At the same time, NF-κB-driven senescence-associated secretory activity and mitochondrial damage signals that engage the NLRP3 inflammasome form a reinforcing circuit that promotes macrophage dysfunction and exhaustion-like impairment of T and natural killer cells. These immune-metabolic disturbances stabilize low-grade chronic inflammation and metabolic instability, helping to explain persistent inflammatory sequelae, airway remodeling, and progressive decline in lung function. Building on these insights, we discuss a translational path centered on composite biomarker panels that integrate immune-exhaustion signatures, senescence mediators, NAD+-SIRT1 status, mitochondrial injury markers, and NLRP3 activity, and we consider low-intensity, multi-target therapeutic strategies designed to overcome the limitations of single-pathway treatments in COPD.
    Keywords:  NAD+–SIRT1 signaling; NLRP3 inflammasome; chronic obstructive pulmonary disease; immunosenescence; inflammaging; metabolic reprogramming; mitochondrial dysfunction
    DOI:  https://doi.org/10.3389/fcell.2026.1756033
  17. Curr Opin Genet Dev. 2026 Mar 24. pii: S0959-437X(26)00029-8. [Epub ahead of print]98 102462
      Regeneration requires coordinated cellular responses that restore tissue structure and function following injury, yet regenerative capacity varies widely across vertebrates. In mammals, regeneration is restricted to specific contexts, including the digit tip, where local tissue environments permit blastema formation and patterned repair. Here, we review emerging insights into the local cues governing mammalian digit tip regeneration, focusing on the roles of the nail organ, inflammatory dynamics, fibroblast heterogeneity, and extracellular matrix mechanics. We then place these mechanisms within a broader systemic context, highlighting how immune, endocrine, and neuroendocrine signals shape regenerative outcomes in diverse models. Together, these studies emphasise regeneration as an organism-wide process integrating local repair programmes with systemic physiological regulation.
    DOI:  https://doi.org/10.1016/j.gde.2026.102462
  18. Tissue Cell. 2026 Mar 22. pii: S0040-8166(26)00161-8. [Epub ahead of print]101 103468
       BACKGROUND: The primary pathogenic mechanism of lower back pain is intervertebral disc degeneration (IVDD), and the phenotypic change of nucleus pulposus cells and matrix degradation are caused by an imbalance in the "inflammation - autophagy - fibrosis" axis. Despite Tong'an decoction's obvious therapeutic benefits, it is unclear if its principal ingredient, quercetin, controls mitochondrial autophagy and postpones IVDD by interfering with TNF signaling.
    METHODS: Tong'an decoction's various components were screened using the traditional Chinese medicine database, and quercetin's main targets were found. By combining transcriptome differential analysis and module analysis, IVDD core genes may be identified. These genes can then be intersected with the autophagy genes to identify autophagy-associated IVDD genes. Joint validation of core genes, additional single-cell sequencing study of cell subpopulation dynamics, and external data validation of core genes expression. The in vivo effectiveness of quercetin was confirmed by imaging and pathological tissue staining, acupuncture rat models, the identification of inflammatory markers, and the RNA detection of important genes. The mechanism of action of quercetin was anticipated using a quercetin target interaction network. Finally, the lipopolysaccharide induced nucleus pulposus cells model was used for molecular mechanism and functional validation.
    RESULTS: 677 IVDD related autophagy genes (such as HIF1A, TNF, BCL2, and LC3) were screened. Functional enrichment shows that these genes are significantly involved in mitochondrial autophagy, apoptosis, ferroptosis, and inflammatory signaling pathways such as TNF, MAPK, and NF-KB. External verification found that the levels of inflammatory factors IL-1 β and TNF - α were elevated in IVDD tissues, and key genes for autophagy and apoptosis were expressed. Single cell sequencing detected different states of nucleus pulposus cells, among which fibrous nucleus pulposus cells are an important pathological type in IVDD. Trajectory analysis reveals the transition of nucleus pulposus cells from steady state to fibrotic phenotype, accompanied by the secretion of inflammatory factors by macrophages. The animal model showed that the collagen arrangement in the nucleus pulposus tissue of the model group was disordered, fibrosis occurred, and the expression of inflammation, autophagy, apoptosis hub genes HIF1A, MAPK1, NFKB, CASP3, etc. was upregulated, while BCL2 was downregulated. Cell experiments have confirmed that inflammatory stimulation leads to depolarization of mitochondrial membrane potential, elevation of autophagy markers, and swelling of mitochondrial structure, which were alleviated by quercetin intervention.
    CONCLUSION: The study found that TNF/IL-1β driven macrophage infiltration stimulates the NF-κB/MAPK pathway, increasing inflammation-induced mitochondrial autophagy dysregulation. Additionally, HIF-1α hypoxic stress accelerates the transition of nucleus pulposus cells into fibroNPCs. Quercetin treatment can drastically reduce TNF signaling, restore mitochondrial autophagy equilibrium, and reverse fibrosis transformation. This study provides a complete proof chain of "components targets phenotype" for treating IVDD with Tong'an Tang, establishing the groundwork for clinical translation.
    Keywords:  Intervertebral disc degeneration; Mitochondrial autophagy; Multi omics techniques; Nucleus pulposus cells; Quercetin; TNF signaling pathway
    DOI:  https://doi.org/10.1016/j.tice.2026.103468
  19. Cell Death Dis. 2026 Mar 25.
      Cartilage degradation is considered a hallmark of end-stage osteoarthritis (OA), characterized by significant alterations in the extracellular matrix (ECM). This study examines the role of pyruvate kinase muscle type 2 (PKM2) dimerization in cartilage degradation and ECM homeostasis in OA. Bioinformatic analyses identified an upregulation of PKM in OA cartilage, particularly within fibrocartilage subpopulations. Elevated expression and dimerization of PKM2 were observed in both human and murine OA cartilage. Chondrocyte-specific PKM2 deficiency, along with treatment using TEPP-46, a PKM2 tetramer stabilizer, reduced OA progression and promoted cartilage matrix production in a murine OA model with destabilization of the medial meniscus (DMM). Mechanistically, PKM2 deficiency or tetramer stabilization promoted mitochondrial fusion and preserved mitochondrial function via disruption of PKM2-ERK interaction, resulting in ERK-dependent upregulation of mitofusin 1 (MFN1), but not mitofusin 2 (MFN2). Notably, AAV-mediated MFN1 knockdown abrogated the chondroprotective effects of PKM2 deficiency. These findings indicate that targeting PKM2 dimerization may represent a promising therapeutic strategy for mitigating OA.Increased PKM2 dimerization in osteoarthritic cartilage plays a pivotal role in extracellular matrix (ECM) degradation during osteoarthritis progression. Stabilization of PKM2 tetramers by TEPP-46 or genetic deletion of PKM2 disrupts PKM2-ERK interaction, promotes upregulation of the mitochondrial fusion protein MFN1, preserves mitochondrial function, and restores ECM homeostasis.
    DOI:  https://doi.org/10.1038/s41419-026-08621-4
  20. Cells. 2026 Mar 15. pii: 522. [Epub ahead of print]15(6):
      Background: During aging, skeletal muscle mass constantly diminishes and myogenic potential declines. At the cellular level, a decline in mitochondrial function is a hallmark of the aging process and the deficiency of the mitochondrial network contributes to a progressive reduction in muscle mass. Autophagic clearance of mitochondria through the process of mitophagy is required to remove impaired or damaged mitochondria, while mitophagy is a key regulator of muscle maintenance. Dysfunctional degradation of mitochondria is increasingly associated with aging (mitophaging), while mechanical stimuli have been shown to ameliorate the aging-induced impaired muscle mass and function; however, less is known about the potential effects of mechanical loading on mitophaging. The aim of the present study was to investigate the effect of mechanical stretching on mitophagy in aged myoblasts, in vitro. Methods: Cell senescence was replicated using a multiple cell division model of C2C12 myoblasts. The control and aged cells were cultured on elastic membranes and underwent passive stretching using a mechanical loading protocol of 15% elongation for 12 h at a frequency of 1 Hz. Cell signaling and gene expression responses of mitophagy-associated and myogenic regulatory factors (MRFs) were assessed through immunoblotting and qRT-PCR of the cell lysates derived from stretched and non-stretched control and aged myoblasts. Results: Mitophagy factor AMP-activated protein kinase (AMPK), mitochondrial biogenesis stimulator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a), and mitophagy/mitochondrial biogenesis factor Parkin were downregulated in control stretched myoblasts compared to non-stretched cells, while the specific mechanical loading protocol used also reduced the phosphorylation of unc-51-like autophagy-activating kinase 1 (p-ULK1) (p < 0.05), as well as the expression of myogenic factor 5 (Myf5) and myogenic factor 4 (myogenin) (p < 0.001). Interestingly, this mechanical loading resulted in increased PGC-1a and Parkin expression (p < 0.05) and induced the previously undetected BCL2 interacting protein 3-like (BNIP3L/NIX) and AMPK expression and p-ULK1 activation in the aged myoblasts. In addition, mechanical stretching differentially affected the expression of MRFs in aged cells, upregulating the early differentiation factor, Myf5 (p < 0.01), while downregulating the late differentiation factor myogenin (p < 0.001). Conclusions: These findings suggest the beneficial effects of mechanical loading on the impaired mitophagy and early differentiation in aged myoblasts, as indicated by the mitophagy initiation and the promotion of mitochondrial biogenesis in these cells. The mechanical loading-induced downregulation of mitophagy and myogenesis in the control myoblasts might indicate their loading-specific differential responses compared to the aged cells.
    Keywords:  mechanical loading; mitophagy; senescence
    DOI:  https://doi.org/10.3390/cells15060522
  21. Antioxidants (Basel). 2026 Mar 22. pii: 399. [Epub ahead of print]15(3):
      Diabetic cardiomyopathy is a specific form of heart dysfunction that occurs in diabetic patients independent of other cardiomyopathies such as coronary artery disease. It significantly contributes to heart failure and mortality in this population. The pathogenesis of diabetic cardiomyopathy mainly includes oxidative stress, inflammatory response, apoptosis and disrupted mitochondrial homeostasis. Mitochondrial homeostasis, encompassing mitochondrial dynamics, mitochondrial oxidative metabolism and mitophagy, is regulated by a variety of signaling pathways and plays a pivotal role in maintaining the normal function of cardiomyocytes. At present, the exact mechanisms underlying diabetic cardiomyopathy pathogenesis remain unclear, and effective prevention and treatment methods are lacking. This review therefore expounds the pathogenesis of diabetic cardiomyopathy from the perspective of mitochondrial homeostasis, providing new approaches to clinical management.
    Keywords:  diabetic cardiomyopathy; mitochondrial homeostasis; pathogenesis
    DOI:  https://doi.org/10.3390/antiox15030399
  22. Sci Transl Med. 2026 Mar 25. 18(842): eaed3762
      For many years, research focused on the immune system's role in the development of type 1 diabetes (T1D). However, mounting evidence suggests a critical involvement of intrinsic pancreatic β cell defects, particularly impaired cellular stress responses, in disease pathology. This shift in understanding is supported by the limited effectiveness of immune-targeting therapies, which have so far managed to delay, rather than prevent or cure, T1D. Here, we discuss why the immune system specifically targets β cells, how stress pathways modify the interaction between β cells and immune cells, β cell resilience, and challenges and opportunities in targeting β cell stress in T1D.
    DOI:  https://doi.org/10.1126/scitranslmed.aed3762
  23. Biomolecules. 2026 03 11. pii: 414. [Epub ahead of print]16(3):
      Type 17 immune responses are primarily mediated by Th17 cells and their effector cytokine interleukin-17 (IL-17), exerting a dual influence on wound healing. IL-17 plays a protective role during the initial stages of acute injury by facilitating rapid neutrophil recruitment, inducing antimicrobial peptide production and reinforcing pro-inflammatory signaling. However, sustained high signal of IL-17 results in a persistent inflammatory response that impairs keratinocyte proliferation and migration, angiogenesis, and nerve regeneration. This review elucidates the IL-17 signal effects and Th17 subset plasticity, which determines wound healing and skin barrier repair through their interactions with microbiota-immune, neuro-immune and metabolic reprogramming systems. Finally, we propose that the new therapeutic methods focus on IL-17 targets through precise spatiotemporal modulation and microenvironmental remodeling to create effective treatments for chronic non-healing wounds.
    Keywords:  IL-17 signaling; Th17 cell plasticity; microenvironmental regulation; skin barrier repair; wound healing
    DOI:  https://doi.org/10.3390/biom16030414
  24. Biomolecules. 2026 Mar 13. pii: 429. [Epub ahead of print]16(3):
       BACKGROUND: Mitophagy is a critical mitochondrial quality control mechanism that limits neuronal injury following cerebral ischemia/reperfusion injury (CI/RI). Tetramethylpyrazine (TMP), a bioactive alkaloid from Ligusticum chuanxiong Hort., exhibits neuroprotective effects in cerebrovascular disorders. However, whether these effects involve mitophagy regulation remains unclear.
    METHODS: CI/RI was induced using a middle cerebral artery occlusion/reperfusion (MCAO/R) model in mice and an oxygen-glucose deprivation/reoxygenation (OGD/R) model in HT22 cells. Neurological function, infarct volume, mitochondrial function, and mitophagy-related markers were assessed. Pharmacological inhibitors and genetic manipulation of YAP and Parkin were used to investigate underlying mechanisms.
    RESULTS: TMP treatment significantly reduced infarct volume and improved neurological deficits in MCAO/R mice, accompanied by enhanced mitophagy, as indicated by increased mitochondrial LC3 recruitment and Parkin expression. In OGD/R-injured HT22 cells, TMP promoted mitophagosome and mitolysosome formation, reduced mitochondrial reactive oxygen species, and restored mitochondrial membrane potential. Inhibition of mitophagy with Mdivi-1 attenuated TMP-mediated neuroprotection. Mechanistically, TMP promoted YAP nuclear localization, and inhibition of YAP or silencing of Parkin abolished TMP-induced mitophagy, while Parkin overexpression restored mitophagy under YAP inhibition.
    CONCLUSIONS: TMP alleviates CI/RI by promoting mitophagy through the YAP/Parkin signaling pathway, suggesting mitophagy modulation as a potential therapeutic strategy for ischemic brain injury.
    Keywords:  YAP/Parkin; cerebral ischemia/reperfusion injury; mitophagy; neuroprotection; tetramethylpyrazine
    DOI:  https://doi.org/10.3390/biom16030429
  25. Adv Biol (Weinh). 2026 Mar;10(3): e00623
      Regenerative medicine is evolving exponentially due to the wide range of therapeutic applications of mesenchymal stromal cells (MSCs), including wound healing. Although the translation of tissue-derived primary MSCs (tMSCs) into clinical practice remains scarce despite preclinical success. The primary causes are donor-associated and batch-to-batch variations, replicative senescence, and the inability of large-scale manufacturing. Recent studies show that the induced MSCs (iMSCs) derived from reprogrammed induced pluripotent stem cells (iPSCs) offer distinct advantages over conventional tMSCs. This review aims to provide a comprehensive comparative analysis of the cellular characteristics, secretome composition (including growth factors, cytokines, and exosome cargo), regenerative capacities, and therapeutic potentials of tMSCs and iMSCs, with a specific focus on their applications in wound healing and tissue regeneration. The iMSCs surpass tMSCs by providing superior regenerative, immunomodulatory, and angiogenic benefits, along with unmatched consistency and scalability. iMSCs and their derivatives have exhibited remarkable capacities to promote angiogenesis, ECM production, re-epithelialization, tissue regeneration, and scarless wound healing in diabetic, cutaneous, mucosal, and burn wounds. These advantages position iMSCs as a next-generation cell therapy for managing both acute and chronic wounds, promising improved clinical outcomes and broader applicability.
    Keywords:  angiogenesis; extracellular vesicles; induced mesenchymal stromal cells; regeneration; secretome; wound healing
    DOI:  https://doi.org/10.1002/adbi.202500623